NGM Clinical Study Site

Chicago, Illinois 60637

0 studies enrolling now · 3 studies all time

What they study most

Bladder Cancer, Colorectal Cancer, Compensated Cirrhosis, Esophageal Cancer, Gastric Cancer, Head Neck Squamous Cell Carcinoma, Melanoma, Metastatic Castration-resistant Prostate Cancer, NASH - Nonalcoholic Steatohepatitis, Non-small Cell Lung Cancer, Nonalcoholic Steatohepatitis, Ovarian Cancer

Studies at this site

• Evaluation of Efficacy, Safety and Tolerability of Aldafermin in a Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study In Subjects With Nonalcoholic Steatohepatitis and Stage 2/3 Fibrosis (ALPINE 2/3) — Completed
• Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy — Completed
• Study of Aldafermin (NGM282) in Subjects With Compensated Cirrhosis (ALPINE 4) — Completed